Jinghua Pharmaceutical Group subsidiary Lu Huaxian led the development of an industry standard which was approved by the National Standards Committee.
Essence Pharmaceutical (002349.SZ) announced that its subsidiary Shandong Lu Huasen Xuan New Materials Co., Ltd. (referred to as "...
Jinghua Pharmaceutical Group (002349.SZ) announced that the industry standard for "1,3-dioxolane" led by its subsidiary Shandong Luhua Senxuan New Materials Co., Ltd. (referred to as "Luhua Senxuan") has been approved by the National Standards Committee and officially announced by the Ministry of Industry and Information Technology. The standard will be officially implemented starting from March 1, 2026.
Related Articles
E Fund Management Co. reduced its holdings of Hangzhou Tigermed Consulting (03347) by 4.17 million shares at a price of approximately HK$44.34 per share.
.png)
According to the 2022 stock incentive plan, Contemporary Amperex Technology (03750) will issue a total of 1,793,900 shares.
PINE TECH(01079): The tender offer deadline has passed, with the tender offeror and its concert parties holding approximately 53.89% of the shares.
E Fund Management Co. reduced its holdings of Hangzhou Tigermed Consulting (03347) by 4.17 million shares at a price of approximately HK$44.34 per share.
According to the 2022 stock incentive plan, Contemporary Amperex Technology (03750) will issue a total of 1,793,900 shares.
PINE TECH(01079): The tender offer deadline has passed, with the tender offeror and its concert parties holding approximately 53.89% of the shares.
